Pfizer Inc.: Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY
Additional dose deliveries beginning December 2021 through 2023
Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY to the EC since the beginning of the pandemic
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY
, the companies' COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 million doses.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005450/en/